- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04302337
Conventional Curettage Adenoidectomy vs Curettage Adenoidectomy With Transoral Endoscopic Residue Ablation in Children
November 6, 2022 updated by: BELDAN POLAT, Istanbul University
Comparison of Short and Long-term Results of Conventional Curettage Adenoidectomy Without Endoscopy Assistance Versus Curettage Adenoidectomy With Transoral Endoscopic Residue Ablation in Children
This prospective study is designed to compare short and long term results of conventional cold curettage adenoidectomy in children performed without doing any endoscopic or mirror examination before ending the operation versus when combined with transoral endoscopic residue ablation using a wand.
Study Overview
Status
Withdrawn
Conditions
Detailed Description
Residual or recurrent adenoid tissue that causes persistence or recurrence of symptoms is observed frequently after conventional cold curettage adenoidectomy.
New techniques to better visualize or excise the tissue in order to prevent this situation are being developed.
This study aims to compare transoral endoscopic controlled adenoidectomy with conventional blind curettage adenoidectomy in terms of recurrent adenoid hypertrophy.
Although there are other studies comparing the results of the two techniques in terms of early residual adenoid tissue and bleeding, no studies comparing the long term results were found in literature.
This prospective study is planned to focus on both early examination of residual tissue and long term recurrence.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Istanbul University, Istanbul Faculty of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 months to 8 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients within 3-12 years old
- Patients undergoing tonsillectomy and adenoidectomy for obstructive sleep disorder
- Patients undergoing adenoidectomy and ventilation tube insertion for chronic otitis media with effusion (OME)
- Patients undergoing adenoidectomy alone for obstructive sleep disorder
- Patients undergoing adenoidectomy alone for chronic OME
- Patients undergoing adenoidectomy alone for chronic sinusitis
Exclusion Criteria:
- Patients not between 3-12 years old
- Patients with craniofacial anomalies
- Revision adenoidectomy
- Proven significant comorbidities
- Systemic diseases
- Bleeding diathesis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Conventional Curettage Adenoidectomy
Adenoidectomy with Beckmann Adenoid Curette
|
Conventional cold curettage adenoidectomy without endoscopic examination for residual tissue.
|
|
Experimental: Curettage Adenoidectomy With Transoral Endoscopic Ablation
Transoral endoscopic adenoidectomy with Coblator 2 system
|
Transoral endoscopic examination of nasopharynx at the end of cold curettage adenoidectomy, and, if found, ablation of residual tissue.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Residual adenoid tissue evaluation with Parikh grade
Time Frame: 1 year after surgery
|
Endoscopic examination of adenoid tissue postoperatively
|
1 year after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bleeding
Time Frame: Up to 2 weeks after surgery
|
The frequency of postoperative bleeding complication
|
Up to 2 weeks after surgery
|
|
Otitis media with effusion
Time Frame: Up to 1 year after surgery
|
Persistency and recurrence of OME after adenoidectomy
|
Up to 1 year after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Beldan Polat, Istanbul University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
October 15, 2020
Primary Completion (Anticipated)
August 1, 2021
Study Completion (Anticipated)
December 1, 2021
Study Registration Dates
First Submitted
February 23, 2020
First Submitted That Met QC Criteria
March 6, 2020
First Posted (Actual)
March 10, 2020
Study Record Updates
Last Update Posted (Actual)
November 9, 2022
Last Update Submitted That Met QC Criteria
November 6, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019/1553
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adenoid Hypertrophy
-
Gaziosmanpasa Research and Education HospitalNot yet recruitingTonsillar Hypertrophy | Voice Disorders in Children | Adenoid HypertrophyTurkey (Türkiye)
-
Nationwide Children's HospitalActive, not recruitingSurgery | Tonsillar Hypertrophy | Adenoid HypertrophyUnited States
-
Arlyne ThungCompletedAdenoid HypertrophyUnited States
-
Bezmialem Vakif UniversityCompleted
-
Rhode Island HospitalCompletedChildren, Only | Tonsillar Hypertrophy | Adenoid HypertrophyUnited States
-
Assiut UniversityNot yet recruitingAdenoid Hypertrophy
-
Melis AKYILDIZRecruitingMalocclusion | Adenoid Hypertrophy | Masseter MuscleTurkey (Türkiye)
-
Dr. Sami Ulus Children's HospitalUnknownRespiratory Tract Infections | Adenoid Hypertrophy | Adenoid Hyperplasia | Preschool Children
-
Selcuk UniversityCompletedAdenoid Disease - Chronic | Complication | Children, Only | Side Effect | Adenoidal HypertrophyTurkey
Clinical Trials on Conventional cold curettage adenoidectomy
-
Medipol UniversityCompletedEndoscopic Coblation AdenoidectomyTurkey (Türkiye)
-
Assiut UniversityNot yet recruitingAdenoid Hypertrophy
-
Rambam Health Care CampusCompletedObstructive Sleep Apnea | Adenoid; Growth
-
Hillel Yaffe Medical CenterUnknownSleep Apnea, Obstructive
-
University Hospital of SplitRecruitingAnesthesia | Neuromuscular Blockade | Intraoperative Bleeding | Anesthesia Complication | Post Operative Hemorrhage | Intraoperative Blood LossCroatia
-
Sanko UniversityUnknownHemostasis After AdenoidectomyTurkey
-
Sheffield Teaching Hospitals NHS Foundation TrustCompleted
-
Barretos Cancer HospitalCompletedWound Infection | CicatrizationBrazil
-
National and Kapodistrian University of AthensActive, not recruiting
-
Showa Inan General HospitalCompletedColorectal CancerJapan